Maryam Kachooeian1, Zahra Mousivand2, Elham Sharifikolouei3, Mehrnoosh Shirangi1, Loghman Firoozpour4, Mohammad Raoufi2,5, Mohammad Sharifzadeh6. 1. Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1416634793, Iran. 2. Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1416634793, Iran. 3. Department of Applied Science and Technology, Politecnico di Torino (POLITO), 10129 Turin, Italy. 4. Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1416634793, Iran. 5. Physical Chemistry I, Department of Chemistry and Biology & Research Center of Micro and Nanochemistry and Engineering (Cμ), University of Siegen, 57076 Siegen, Germany. 6. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1416634793, Iran.
Abstract
Wound healing is one of the most complex biological processes. Studies show that Matrixyl (MTI), known as a cosmetic peptide, can lead to a faster healing process. The contribution of MTI to collagen formation during wound healing also depends on its mode of delivery and its release over time. Here, we investigate two modes of MTI-delivery system, the influence of MTI patch for wound healing application in comparison with MTI cream. In this study, animals were randomly divided into seven groups and studied for 21 days: patches containing two different concentrations of MTI (P-MTI-0.1 mg and P-MTI-1 mg), a cream containing MTI (C-MTI-1 mg), a patch (P-MTI-0), a cream with no MTI (C-MTI-0), a positive control (Comfeel), and a negative control (sham) group. To study the wound healing process, the change in collagen density, angiogenesis, epitheliogenesis, histopathology, immunohistochemical analysis, and wound area through imaging was monitored and measured. The macroscopic results showed that wound healing was improved from 63.5 up to 81.81% in treatment groups compared to that in the negative control group (P < 0.05 and P < 0.001). In addition, C-MTI-1 and P-MTI-1 had a larger impact on wound healing compared to that in the positive control group (Comfeel, P < 0.05). In hematoxylin and eosin (H&E) staining analysis, the rejuvenation of skin appendage was visible in both groups of cream and patches with MTI. According to the obtained results, the re-epithelialization had a higher range for the patch with MTI in comparison with cream containing MTI and positive control.
Wound healing is one of the most complex biological processes. Studies show that Matrixyl (MTI), known as a cosmetic peptide, can lead to a faster healing process. The contribution of MTI to collagen formation during wound healing also depends on its mode of delivery and its release over time. Here, we investigate two modes of MTI-delivery system, the influence of MTI patch for wound healing application in comparison with MTI cream. In this study, animals were randomly divided into seven groups and studied for 21 days: patches containing two different concentrations of MTI (P-MTI-0.1 mg and P-MTI-1 mg), a cream containing MTI (C-MTI-1 mg), a patch (P-MTI-0), a cream with no MTI (C-MTI-0), a positive control (Comfeel), and a negative control (sham) group. To study the wound healing process, the change in collagen density, angiogenesis, epitheliogenesis, histopathology, immunohistochemical analysis, and wound area through imaging was monitored and measured. The macroscopic results showed that wound healing was improved from 63.5 up to 81.81% in treatment groups compared to that in the negative control group (P < 0.05 and P < 0.001). In addition, C-MTI-1 and P-MTI-1 had a larger impact on wound healing compared to that in the positive control group (Comfeel, P < 0.05). In hematoxylin and eosin (H&E) staining analysis, the rejuvenation of skin appendage was visible in both groups of cream and patches with MTI. According to the obtained results, the re-epithelialization had a higher range for the patch with MTI in comparison with cream containing MTI and positive control.
Skin, as the largest organ
in the body, encloses the organs, tissues,
and bodily fluids and is thought to be an effective barrier against
external invasions.[1] The epidermis, dermis,
and hypodermis are the three main layers of skin. Skin layers could
lose their natural cohesion due to a variety of factors including
cuts, physical damage, and burns. This might result in a type of tissue
rupture (wound) called skin ulcers.[2] Created
wounds could be acute or chronic (also known as nonhealing wounds).[3] The wound healing process is a complex and relatively
long process that is initiated by an immune response to the wound,
and it continues until the damaged tissue is completely repaired.[4] This process involves both cellular and molecular
events. Therefore, after skin damage, inflammatory responses take
place and the process of the production of new collagen by dermal
cells begins, leading to a new covering tissue formation in the epidermis.Peptides are compounds formed by the binding of several amino acids,
through the binding of the carboxyl group of amino acid with the amino
group of another amino acid, and the properties of these substances
mainly depend on the amino acid sequence. In recent years, the use
of peptide medications in the pharmaceutical industry, and in particular
for wound healing applications, has been significantly increased due
to their unique properties such as high propensity and specificity,
quick and easy synthesis, small size, good permeability, low drug
interaction, labeling ability, and less tissue accumulation.[5] In fact, the peptides in skincare products offer
an assortment of benefits including antiaging and sun protection to
fasten mending of wounds.[6] Numerous kinds
of research have reported peptides’ benefits in reducing fine
lines and wrinkles, tightening the skin, reducing the size of open
skin pores, reducing skin inflammation, protecting against sun damage,
and accelerating wound healing.[7]Matrixyl (MTI) is a palmitoyl-pentapeptide, also known as a peptide.
It is a new compound that has a profound influence on collagen formation.[8] It contains five amino acids (Lys-Thr-Thr-Lys-Ser-OH
or KTTKS-OH) that bind to a 16-carbon aliphatic chain at the N-terminus,
and its molecular structure is shown in Figure . The aliphatic end increases the drug’s
entry into the skin’s sebum structure and its impact by increasing
the compound’s lipophilicity. Typically, the problem of passing
through the skin in topical products is due to the ionic nature of
some compounds, which, as previously stated, is solved in Matrixyl
by adding palmethoyl.[9]
Figure 1
Molecular structure of
MTI with Pal-Lys-Thr-Thr-Lys-Ser-OH.
Molecular structure of
MTI with Pal-Lys-Thr-Thr-Lys-Ser-OH.In vitro studies indicate that MTI, palmitoyl-pentapeptide,
is
one of the signal peptides. It has been discussed that the mechanism
by which MTI promotes collagen formation is based on the peptide reaching
the fibroblast in the dermis after passing through the skin and stratum
corneum. The peptide binds to the cell surface receptor, which is
linked to a transducer, and data is transmitted to the cell via various
signaling pathways. These pathways are similar to the TGF-β
pathway since they all lead to increased collagen production. Furthermore,
MTI promotes cellular processes such as collagenase inhibition to
prevent collagen degradation, which eventually increases extracellular
matrix protein production.[10,11]Lintner et al.
have demonstrated that using MTI as cream has a
significant effect on increasing the collagen in the dermis and on
reducing wrinkles.[12] Another study was
conducted in 2016 to evaluate the effect of palmitoyl-pentapeptide
(Pal-KTTKS) on wound contractility in relation to connective tissue
growth factor and smooth muscle actin expression and showed a balance
between the wound healing properties and profibrotic abilities of
pentapeptide KTTKS. Therefore, it was suggested to consider palmitoyl-pentapeptide
as a therapeutic agent in the prevention of scar lesions.[13]Skin patches are also one of the most
recent shapes of skin products.
Cosmetic patches are a unique skin delivery system that supplies the
body’s demand for ingredients and allows the transdermal transfer
of active compounds.[14] Today, skin patches
are widely used for various drug delivery purposes such as helping
to quit smoking, reducing pain, controlling nausea, and treating hormonal
disorders, and as contraceptives in women.[15] However, their utilization as skin patches is still limited and
has several obstacles due to restrictions on the selection of prescription
drugs from the skin pathway and the variability of skin absorption
of the drug in different people.[16]To date, no comprehensive study has compared the impact of patch
peptides on wound healing compared to the common peptide cream. In
this regard, we have synthesized Matrixyl, analyzed different parameters
including epithelialization counting and collagen union and histological
studies, and inspected whether the use of the patch form was especially
superior to the use of the cream.
Materials and Methods
All chemicals
were purchased from Sigma-Aldrich Chemicals.
Synthesis of Matrixyl
The peptide
was prepared through solid-phase synthesis based on the Fmoc strategy.[17] Fmoc (fluorenylmethyloxycarbonyl) was first
introduced as an amino acid protector in 1970. In this strategy, the
first amino acid has an amino acid moiety protected by Fmoc. This
group is unstable under alkaline conditions and separates from the
amino acid. 2-Chlorotrityl chloride (2-CTC) resin was used for Matrixyl
synthesis. The synthesis involved loading of C-terminal amino acid
to resin; deprotection, i.e., the removal of N-terminal protecting
group (PG) at amino residue; activation of the next amino acid at
carboxy residue; coupling reaction; and finally, repeating this cycle
until crude peptide was cleaved off the resin. To ensure amino acid
coupling to the peptide–resin chain, the Kaiser test was used.
The schematic representation of the Matrixyl synthesis process is
presented in Figure . The validity of the synthesis was controlled by the Kaiser test,
and the protocol is explained in the Supporting Information.
Figure 2
Schematic representation of the Matrixyl synthesis process.
Schematic representation of the Matrixyl synthesis process.
Evaluation of Synthesized Matrixyl (Pal-KTTKS)
The mass spectrometer equipped with a Turbo ion spray source (Agilent,
641 QQQ) was used to identify and confirm the synthesized peptide
structure (presented in Figure S1). Assay
and purity of peptide were measured using high-performance liquid
chromatography (HPLC) (Agilent 1200 instrument). The assay of the
synthesized sample was compared with a white powder of Matrixyl (CAS
No. 214047-00-4) purchased from Sigma-Aldrich (presented in Figure S2 and Table S1). Likewise, the purity
of MTI was measured by HPLC and compared to that of distilled water,
which was used as a blank (see Figure S3 and Table S2). Residual solvents after synthesis were measured by headspace
gas chromatography equipped with a flame ionization detector based
on USP ⟨467⟩ (Figure S4).
The presence of heavy metals was assessed via calorimetry. The pH
of the synthesized MTI was also measured at 1% w/w in distilled water
by a pH meter (Table S3), and the moisture
content was measured by Karl Fischer (Table S4).
Patch Formulation and Fabrication
Biopolymeric solutions containing hyaluronic acid were prepared at
the concentration of 0.36% w/v in the deionized water. The solution
was first mixed by a vortex for 1 h, followed by another hour of mixing
on a hot stirrer (400 rpm). Thereafter, the solution was filtered
by a 0.22 μm membrane to remove undissolved fragments until
a very clear solution was obtained. An optimized 400 nm pore size
ceramic membrane was selected to achieve the required skin properties
of the patch and was mounted under the setup with an O-ring. Moreover,
the extrusion process was conducted under a controlled temperature
(37–39 °C) to facilitate the evaporation of the solvents
from an extruded nanofiber. The fed solution was passed through the
membrane by a syringe pump (Standard PHD ULTRA CP 4400, Harvard) at
a constant flow rate of 200 μL/min. Matrixyl (MIT) was added
in the concentrations of 5 × 10–5% w/v and
5 × 10–4% w/v. In addition, biopolymeric solutions
were dried at 40 °C in a culture hood for 10 h.[18]
In Vivo Assessment of Wound Healing Activity
A total of 42 male albino Wistar rats weighing 200–250 g
were used (6 in each group). The rats were kept in standard vivarium
conditions (60% relative humidity and a temperature of 25 °C)
and fed standard laboratory food and water. The experiment was approved
by the Tehran University of Medical Sciences’ animal ethics
guidelines. The animals were shaved at the dorsal part with intraperitoneal
injections of ketamine (90 mg/kg) and xylazine (10 mg/kg) under anesthesia.
On the dorsal area, a large wound was inflicted. Comfeel, a ready-to-wear
dressing available in the market, was used as a positive control group.
It consists of a semipermeable polyurethane film coated with a flexible,
cross-linked adhesive containing sodium carboxymethylcellulose and
calcium alginate as the principal absorbent and gel-forming agents.
Sham was used as a negative control group. Generally, a sham was defined
as a group of animals that are not exposed to any variable in the
study, and in this case, their wounds were only bandaged without any
further treatments. The animals were kept in separate cages and divided
into seven groups: positive control (Comfeel), negative control (sham),
P-MTI-0 (patch without any active substance), P-MTI-0.1 (0.1 mg of
Matrixyl loaded on the patch), P-MTI-1 (1 mg of Matrixyl loaded on
the patch), and C-MTI-1 (1 mg of Matrixyl in formulated cream), and
C-MTI-0 (cream base). For 21 days, a layer of cream and patches was
applied to wounds in different groups every 24 h. The wound healing
process was observed and recorded by a camera (Canon EOS 4000D) using
a ruler as a scale. ImageJ (version 1.46) software was used to calculate
the wound reduction percentage of the wound area.
Histopathological and Immunohistochemical
Analysis
On days 7, 14, and 21 postsurgery, the animals were
sacrificed, and the scar tissues were harvested with a 0.5 cm margin
of surrounding unwounded tissue. Half of each sample was immediately
fixed in 10% neutral buffered formalin (pH 7.26) for 48 h and dehydrated,
embedded in paraffin, and sectioned into 5 mm thickness. The dehydration
process was based on the use of ethanol with gradually increasing
concentration; therefore, samples were first placed in ethanol 70%
and then transferred to ethanol 80, 90, and 99.999% respectively.
Finally, the sections were stained with hematoxylin and eosin (H&E)
and Masson trichrome (MT). The samples were further coded and an independent
pathologist evaluated the slides using light microscopy (Olympus BX51;
Olympus, Tokyo, Japan) to ensure a nonbiased evaluation.
Angiogenesis and Collagen Density
The number of blood vessels per slide in five microscopic fields
(HPFs) was randomly counted and the average for three replications
was reported. The percentage of collagen tissues in five microscopic
fields with 100× magnification that were randomly selected was
calculated using Image Pro-Plus software (version 6) based on the
difference in color density and the average for three replications
was reported.
Statistical Analysis
All results
were compared by posthoc Newman–Keuls multiple comparison test
using a one-way ANOVA analysis. Results with P values
less than 0.05 were considered statistically significant. Statistical
analyses were performed using GraphPad Prism, version 7.
Results
Patches were synthesized as
described previously in Section . To confirm
the successful synthesis of Matrixyl, its structure was detected and
confirmed using mass spectroscopy (Figure S1). The assay of the peptide was evaluated based on the anhydrous
method, and the value of 100.7% was calculated for it (Figure S2 and Table S1). Additionally, the purity
of peptide was evaluated through HPLC analysis and estimated to be
97% (see Figure S3 and Table S2).The wound healing process for different groups of the study, as
summarized in Table , was compared on days 0, 7, 14, and 21 and are shown in Figure . According to this
figure, from day 0 to 7, no specific difference between defined groups
was observed. On the 14th day, however, P-MTI-1 (patch with a high
concentration of MTI), P-MTI-0.1 (patch with a low concentration of
MTI), and C-MTI-1 had more alterations than sham and P-MTI-0 (patch
without MTI). Nevertheless, on the final day of the study, almost
all groups showed good restorative benefits. This observation was
further studied quantitatively for the change in the wound healing
area, and its analysis is shown in Figure . The full values are also presented in Table .
Table 1
Summary of the Studied Groups
groups
C-MTI-0
C-MTI-1
P-MTI-0.1
P-MTI-1
P-MTI-0
Comfeel
sham
MTI concentration (mg/mL)
0
1
0.1
1
0
0
0
Figure 3
Macroscopic images of
the induced wound on the dorsal area of the
rat on days 0, 7, 14, and 21 in the studied groups: C-MTI-0 (C0),
C-MTI-1 (C1), P-MTI-1 (P1), P-MTI-0.1 (P0.1), P-MTI-0 (P0), sham negative
control, and Comfeel positive control.
Figure 4
Quantitative analysis of wound area reduction in C-MTI-0,
C-MTI-1,
P-MTI-1, P-MTI-0.1, P-MTI-0, sham negative control, and Comfeel positive
control on (A) day 7, (B) day 14, and (C) day 21. *P < 0.05, **P < 0.01, and ***P < 0.001.
Table 2
Comparison of Wound Area Change (%)
in Treatment Groups on Days 7, 14, and 21a
groups/days
day
7
day
14
day 21
C-MTI-0 (C0)
60.51 ± 6.80
65.74 ± 6.01
68.06 ± 2.26*Xb
C-MTI-1 (C1)
61.53 ± 8.78
86.12 ± 5.41#Xa
90.03 ± 4.42#Xa,*Xb
P-MTI-0 (P0)
65.87 ± 8.17
72.73 ± 8.98
73.411 ± 1.79
P-MTI-0.1 (P0.1)
63.73 ± 5.37
76.63 ± 3.56**Xa
86.96 ±7.07#Xa
P-MTI-1 (P1)
68.24 ± 7.76
88.30 ± 0.43#Xa
94.71 ± 3.04##Xa,**Xb
sham
(ctrl−)
60.51 ± 6.80
60.69 ± 0.90
69.72 ± 5.17
Comfeel (ctrl+)
61.58 ± 8.38
80.23 ± 7.41
80.39 ± 2.08
Values are expressed as mean ±
standard deviation for each group. Significant differences: *P < 0.05, **P < 0.01, and ***P < 0.001. Xa: in comparison to negative control,
Xb: in comparison to positive control.
Macroscopic images of
the induced wound on the dorsal area of the
rat on days 0, 7, 14, and 21 in the studied groups: C-MTI-0 (C0),
C-MTI-1 (C1), P-MTI-1 (P1), P-MTI-0.1 (P0.1), P-MTI-0 (P0), sham negative
control, and Comfeel positive control.Quantitative analysis of wound area reduction in C-MTI-0,
C-MTI-1,
P-MTI-1, P-MTI-0.1, P-MTI-0, sham negative control, and Comfeel positive
control on (A) day 7, (B) day 14, and (C) day 21. *P < 0.05, **P < 0.01, and ***P < 0.001.Values are expressed as mean ±
standard deviation for each group. Significant differences: *P < 0.05, **P < 0.01, and ***P < 0.001. Xa: in comparison to negative control,
Xb: in comparison to positive control.According to Figure A, at the end of the first week (day 7), the wound
area reduction
in all defined groups is comparable; meanwhile, going to Figure B, there is a significant
wound area reduction (P < 0.001) in all groups
that contain MTI in comparison with the negative control group (sham).
Indeed, the most significant wound closure for the defined group in
comparison with the negative control group is observed in the last
week of the study (*P < 0.05, **P < 0.01, and ***P < 0.001) (Figure C). This could indicate that
the effectiveness of the defined groups with active compounds (MTI)
does not decrease over time. Furthermore, it could be noted that the
results from the patch with a low concentration of MTI (P-MTI-0.1)
showed similar effects to those of the positive control group (Comfeel).
On the other hand, wound contraction with Matrixyl cream and patch
with a high concentration of the MTI (C-MTI-1 and P-MTI-1) was significantly
higher than the positive control group (Comfeel) (*P < 0.05).Histology analysis studies the structure and function
of tissues
and their components, and it is a suitable method for evaluating the
effectiveness of various forms of pharmaceutical components and cosmetics.
In this work, histological analysis of the skin wounds was performed
by H&E staining on days 7, 14, and 21. In these images, magnifications
of 40 and 100 were utilized for coloring H&E. Histological analysis
of the skin wounds on day 7 is shown in Figure . In this figure, the H&E staining crusty
scab indicated the production of granulation tissue. According to
this analysis, there was no significant difference among the studied
groups at this time point. The histopathological evaluation of the
positive control (Comfeel) showed severe infiltration of inflammatory
cells into the wound area. On this day, epidermis and dermis started
to form for the C-MTI-0 and C-MTI-1 treatment groups. The wound healing
process depended on collagen synthesis. Therefore, to further investigate
the effect of creams and patches on wound healing, sections of animal
skin tissues were stained with Masson trichrome (MT) staining (marked
as MT*100). This staining was used to recognize the progress of collagen
synthesis during granulation tissue formation and matrix remodeling.
Collagen fibers were stained blue-green in the MT staining method,
in which the intensity of this color corresponded to the relative
amount of deposited total collagen and reflects the advancement of
collagen synthesis and remodeling. According to MT staining, the collagen
production in all groups is comparable.
Figure 5
H&E and MT-stained
microscopic sections of healed incisions
in the different treatment groups on day 7 post-treatment, arrows:
crusty scab. (A) C-MTI-0, (B) C-MTI-1, (C) P-MTI-1, (D) P-MTI-0.1,
(E) P-MTI-0, (F) negative control, and (G) positive control.
H&E and MT-stained
microscopic sections of healed incisions
in the different treatment groups on day 7 post-treatment, arrows:
crusty scab. (A) C-MTI-0, (B) C-MTI-1, (C) P-MTI-1, (D) P-MTI-0.1,
(E) P-MTI-0, (F) negative control, and (G) positive control.Moving to the H&E analysis on day 14, presented
in Figure , we observed
the
same crusty scab in all groups as a sign of granulation tissue. Histological
examination revealed that epithelialization, one of the most important
wound healing processes, started on this day. Although a narrow layer
of the epithelial cell was formed in the positive control group (Comfeel),
inflammation was also observed for it. Furthermore, epidermal proliferation
was observed for both low and high MTI concentrated patches (P-MTI-0.1,
P-MTI-1). For P-MTI-0.1, the re-epithelialization and rete ridges
were observed on the same date. The inflammatory response in the cream
treatment groups, C-MTI-0 and C-MTI-1, was considerably decreased.
The MT staining analysis on this date showed an increased collagen
production and rete ridge in the MTI-containing groups and the positive
control group (Comfeel).
Figure 6
H&E and MT-stained microscopic sections
of healed incisions
in the different treatment groups on day 14 post-treatment. Black
arrows: re-epithelialization; blue arrows: rete ridges. (A) C-MTI-0,
(B) C-MTI-1, (C) P-MTI-1, (D) P-MTI-0.1, (E) P-MTI-0, (F) negative
control, and (G) positive control.
H&E and MT-stained microscopic sections
of healed incisions
in the different treatment groups on day 14 post-treatment. Black
arrows: re-epithelialization; blue arrows: rete ridges. (A) C-MTI-0,
(B) C-MTI-1, (C) P-MTI-1, (D) P-MTI-0.1, (E) P-MTI-0, (F) negative
control, and (G) positive control.Finally, moving to H&E analysis on day 21 (Figure ), in the positive
control
group, the epithelialization process was completed, and the inflammatory
cells were significantly reduced in comparison to the negative control
at the same time point. Furthermore, the inflammatory response and
granulation tissue were gradually decreased for both low and high
concentrations of MTI patches (P-MTI-0.1, P-MTI-1). These treatment
groups had more resemblance to normal skin compared to other defined
groups due to the formation of the thin epidermis, the presence of
normal rete ridges, and the rejuvenation of skin appendages. In this
manner, the presence of MTI in these patches realized the advantageous
impacts of the repairing process. On this day, various degrees of
re-epithelialization were formed in all the replicates of cream without
MTI and cream with MTI treatment groups (C-MTI-0, C-MTI-1). The MT
staining on day 21 showed that there was a clear increase in the density
of blue in the patch with high concentration and patch with a low
concentration of MTI (P-MTI-0.1, P-MTI-1) and relatively less in the
positive control groups (Comfeel) and the group with cream with Matrixyl
(C-MTI-1). Finally, it was evident that collagen production in patch
groups was significantly higher than that in the cream groups.
Figure 7
H&E- and
MT-stained microscopic sections of healed incisions
in the different treatment groups on day 21 post-treatment. Arrows:
rejuvenation of skin appendages. (A) C-MTI-0, (B) C-MTI-1, (C) P-MTI-1,
(D) P-MTI-0.1, (E) P-MTI-0, (F) negative control, and (G) positive
control.
H&E- and
MT-stained microscopic sections of healed incisions
in the different treatment groups on day 21 post-treatment. Arrows:
rejuvenation of skin appendages. (A) C-MTI-0, (B) C-MTI-1, (C) P-MTI-1,
(D) P-MTI-0.1, (E) P-MTI-0, (F) negative control, and (G) positive
control.The collagen density and angiogenesis quantitative
analysis based
on H&E figures were performed and are shown in Figure , and their exact values are
reported in Table . Based on the angiogenesis analysis, the treatment response in the
cream with MTI group was better than those of cream without MTI according
to histomorphometric analysis. Based on the collagen density analysis,
among all defined groups, the patch with a low concentration and the
patch with a high concentration of MTI had the greatest collagen synthesis,
followed by Comfeel. Hence, the positive effect of MTI on wound healing
was quite evident. In contrast, the rate of collagen fiber synthesis
and deposition in the wound area was the lowest in the negative control
group. The appropriate angiogenesis had a Gaussian trend as reported
before by DiPietro[19] and was observed in
the following groups: P-MTI-0.1, P-MTI-1, C-MTI-0, C-MTI-1, and Comfeel.
When the angiogenic process continued to increase until the end of
the study, it was an unfavorable result, which was observed in the
sham group and negative control studies. This inappropriate process
was also evident in wound closure.
Figure 8
(A) Collagen density quantitative analysis
and (B) angiogenesis
quantitative analysis of C-MTI-0, C-MTI-1, P-MTI-1, P-MTI-0.1, P-MTI-0,
sham negative control, and Comfeel positive control. * P < 0.05, ** P < 0.01, ***P < 0.001.
Table 3
Histomorphometric Analysis of Different
Experimental Groups
group
angiogenesis/5HPF (n = 3)
collagen
content (%) (n = 3)
C-MTI-0
54.3 ± 7.7 (21 days)
68.3 ± 2.5 (21 days)
C-MTI-1
46 ± 4.5 (21 days)
65.3 ± 9.6 (21 days)
P-MTI-0
174.3 ± 11.6 (21 days)
37.3 ± 4.7 (21 days)
P-MTI-1
21.3 ± 2.5 (21 days)
89 ± 3.6 (21 days)
P-MTI-0.1
22.6 ± 4.5 (21 days)
85 ± 4.5 (21 days)
sham
137.3 ± 13.6 (21 days)
46.6 ± 3.5 (21 days)
Comfeel
38.3 ± 2.5 (21 days)
66.6 ± 5.6 (21 days)
(A) Collagen density quantitative analysis
and (B) angiogenesis
quantitative analysis of C-MTI-0, C-MTI-1, P-MTI-1, P-MTI-0.1, P-MTI-0,
sham negative control, and Comfeel positive control. * P < 0.05, ** P < 0.01, ***P < 0.001.Epithelialization on day 21 was assessed semiquantitatively
on
a five-point scale: 0 (without new epithelialization), 1 (25%), 2
(50%), 3 (75%), and 4 (100%) (Table ). All defined groups were compared with the sham group.
Both patches with high and low concentrations of MTI had the highest
rate of epithelialization compared to the negative control (***P < 0.001). Furthermore, the highest amount of efficacy
was observed for the patch groups, the cream with Matrixyl group,
and Comfeel group, respectively (**P < 0.01).
However, the least amount of efficacy was observed for the sham group
(*P < 0.05) (Table ).
Table 4
Histomorphometric Analysis of Different
Experimental Groupsa
group
epitheliogenesis
score (N = 3)
C-MTI-0
2, 3, 2 (21 days)*
C-MTI-1
3, 3, 3 (21 days)**
P-MTI-0
2, 1, 1 (21 days)
P-MTI-1
3, 4, 3 (21 days)***
P-MTI-0.1
4, 3, 4 (21 days)***
sham
1, 1, 1 (21 days)
Comfeel
3, 3, 2 (21 days)**
*, **, ***: values indicate treatment
group vs nontreatment (sham) group; *P < 0.05,
**P < 0.01, ***P < 0.001.
*, **, ***: values indicate treatment
group vs nontreatment (sham) group; *P < 0.05,
**P < 0.01, ***P < 0.001.
Discussion
In this work, we successfully
synthesized Matryxil (MTI), which
was confirmed by mass spectroscopy, and investigated its effect on
wound healing when utilized in the form of cream compared to transdermal
patches. We prepared seven groups of samples with different concentrations
of MTI: positive control (Comfeel), negative control (sham), P-MTI-0
(patch without any active substance), P-MTI-0.1 (0.1 mg of Matrixyl
loaded on the patch), P-MTI-1 (1 mg of Matrixyl loaded on the patch),
C-MTI-1 (1 mg of Matrixyl in formulated cream), and C-MTI-0 (cream
base), which were studied for their collagen density, angiogenesis,
epitheliogenesis, histopathology, immunohistochemical analysis, and
change in wound area.The macroscopic analysis of the wound
healing process indicated
that a minimum 14-day post-treatment was required to observe a meaningful
difference among the groups. On day 14, the effect and the contribution
of MTI to wound healing were quantitively evident. Overall, these
findings were in accordance with the findings reported by Jones et
al., who studied the effect of C16-KTTKS amphiphile peptide on collagen
stimulation in human fibroblasts and showed that the stimulation of
collagen production was correlated with the concentration of the peptide.[11] In fact, both patches with low and high amounts
of MTI, as well as cream with MTI showed a better wound closure compared
with the positive control group. Another study conducted by Katayama
et al. showed that the pentapeptide (KTTKS) was the minimum sequence
necessary for the potent stimulation of collagen and fibronectin production
in a variety of mesenchymal cells.[20] Indeed,
this was the exact sequence present in Matrixyl. On day 21, the same
trend was observed, showing the most promising results for cream and
patch with 1 mg of MTI. In this analysis, even though the best result
was observed for the Patch with 1 mg of MTI, no significant difference
between the patch and the cream with the same concentration of MTI
was detected.The collagen formation in each group, however,
had shown a different
trend. In fact, both patches with high and low concentrations of MTI
(P-MTI-0.1 and P-MTI-1) showed an improved collagen formation with
89 ± 3.6 and 85 ± 4.5% in comparison with C-MTI-1 (65.3
± 9.6%). This means that the mode of delivery could impact collagen
formation during the wound healing process.Furthermore, H&E
analysis showed that both patches with high
and low concentrations of MTI had the highest rate of epithelialization
compared to the negative control (***P < 0.001).
Furthermore, the highest amount of efficacy was observed for the patch
groups, the cream with Matrixyl groups, and Comfeel group (**P < 0.01).
Conclusions
This study indicated the
importance of active substances on the
wound healing process, as well as its mode of delivery, cream vs patch.
Our analysis showed that the patch groups administered with active
substance peptides in comparison to other treatment groups contributed
to an improved wound healing process with the best cosmetic appearance,
with normal thickness of the epidermal layer and the rejuvenation
of the hair follicles and skin appendages. In contrast, the control
negative group (sham), at all days of treatment, showed polymorphonuclear
inflammatory cell (PMN) infiltration and granulation tissue formation.
In fact, the epidermal layer could not be formed even by the end of
day 21 and the wound was covered by a crusty scab. Micrographs of
the patch without Matrixyl groups (P-MTI-0) showed similar results
to the negative control group by forming a crusty scab covering the
inflamed wound area without the epidermal formation. This indicates
the necessity of the presence of MTI owing to its therapeutic effects
in wound healing.
Authors: H Mahdavi; Z Kermani; G Faghihi; A Asilian; H Hamishehkar; A Jamshidi Journal: Indian J Dermatol Venereol Leprol Date: 2006 Nov-Dec Impact factor: 2.545